September 15, 2019

Olivia Brasher of North Little Rock, a junior medical student at the University of Arkansas for Medical Sciences (UAMS), has been awarded a $20,000 Arkansas Blue Cross and Blue Shield Primary Care Scholarship, which encourages aspiring physicians to pursue primary care practices in rural Arkansas.

Drake Cullum of Bono, a senior medical student at the University of Arkansas for Medical Sciences (UAMS), has been awarded the same scholarship.

September 15, 2019

A scientist at Arkansas Children’s Research Institute (ACRI) and the University of Arkansas for Medical Sciences (UAMS) is leading research to make kidney transplants easier and more survivable for patients.

Dr. Nirmala Parajuli, a scientist at ACRI and an assistant professor of Pharmacology and Toxicology in the UAMS College of Medicine, received a $300,000 grant from the American Heart Association (AHA) to study a protein that has been identified as pivotal in improving outcomes of transplant patients who receive kidneys kept in cold storage before transplant.

September 15, 2019

Dr. Meaghan Masini has joined CHI St. Vincent Primary Care Clinic, located at the West Gate in Hot Springs Village. Masini specializes in geriatric medicine and help ensure residents of the village continue to have access to care right in the community where they live. She is now seeing patients at the clinic located at 4417 Highway 7 North.

September 15, 2019

Research to better understand chlamydia, potentially informing the development of a vaccine for the infection, is underway at Arkansas Children’s Research Institute (ACRI) and the University of Arkansas for Medical Sciences (UAMS) after the National Institutes of Health (NIH) awarded the project $420,000.

September 15, 2019

Prostate cancer is now the most common cancer among men after skin cancer, according to the American Cancer Society.

The risk of developing prostate cancer progressively increases with age and screening is suggested for men beginning in their 40s and 50s. There are also certain groups of men at higher risk – both for being diagnosed with, and dying from, prostate cancer.